Localized injections of midazolam into the amygdala and hippocampus induce differential changes in anxiolytic-like motor activity in mice

Behavioural Pharmacology

Volumn 17, Issue 4, 2006, Pages 349-356

  Heldt, Scott A ^a   Ressler, Kerry J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Anxiolytic; Benzodiazepine; Hippocampus; Locomotor activity; Mouse

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; MIDAZOLAM;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; DRUG MEGADOSE; HIPPOCAMPUS; HYPERACTIVITY; LOW DRUG DOSE; MALE; MICROINJECTION; MOTOR ACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN FIELD BEHAVIOR; RELIABILITY; SEDATION; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANXIETY; GABA MODULATORS; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICROINJECTIONS; MIDAZOLAM; MOTOR ACTIVITY;

EID: 33747493746     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000224386.86615.e0     Document Type: Article

References (55)

1. Anagnostopoulos AV, Mobraaten LE, Sharp JJ, Davisson MT (2001). Transgenic and knockout databases: behavioral profiles of mouse mutants. Physiol Behav 73:675-689.
2. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch K-P, Schmitt A (2005). The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131:953-967.
3. Bailey DJ, Tetzlaff JE, Cook JM, He X, Helmstetter FJ (2002). Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning. Neurobiol Learn Mem 78:1-10.
4. Bast T, Feldon J (2003). Hippocampal modulation of sensorimotor processes. Prog Neurobiol 70:319-345.
5. Belzung C, Griebel G (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125:141-149.
6. Blanchard DC, Griebel G, Blanchard RJ (2001). Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25:205-218.
7. Bothe GWM, Bolivar VJ, Vedder MJ, Geistfeld JG (2004). Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav 3:149-157.
8. Carvalho MC, Albrechet-Souza L, Masson S, Brandao ML (2005). Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Braz J Med Biol Res 38:1857-1866.
9. Da Cunha C, Wolfman C, Levi de Stein M, Ruschel AC, Izquierdo I, Medina JH (1992). Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist. Funct Neurol 7:401-405.
10. Da Cunha C, Roozendaal B, Vazdarjanova A, McGaugh JL (1999). Microinfusions of flumazenil into the basolateral but not the central nucleus of the amygdala enhance memory consolidation in rats. Neurobiol Learn Mem 72:1-7.
11. Dawson GR, Crawford SP, Collinson N, Iversen SD, Tricklebank MD (1995). Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berlin) 118:316-323.
12. Fanselow MS and Kim JJ (1992). The bezodiazepine inverse agonist DMCM as an unconditional stimulus for fear-induced analgesia: Implications for the role of GABA-sub (A) receptors in fear-related behavior. Behav Neurosci 106: 336-344.
13. Flicker C, Geyer MA (1982). Behavior during hippocampal microinfusions. III. Lidocaine versus picrotoxin. Brain Res 257:129-136.
14. Gonzalez LE, Andrews N, File SE (1996). 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction, but not in the elevated plus-maze. Brain Research 732:145-153.
15. Gonzalez LE, Ouagazzal AM, File SE (1998). Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci 10: 3673-3680.
16. Green S, Vale AL (1992). Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav Pharmacol 3:261-264.
17. Harris JA, Westbrook RF (1995). Effects of benzodiazepine microinjection into the amygdala of periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 109:295-304.
18. Helmstetter FJ (1993). Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala. Pharmacol Biochem Behav 44:433-438.
19. Hevers W, Luddens H (1998). The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18:35-86.
20. Hodges H, Green S, Glenn B (1987). Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology (Berlin) 92:491-504.
21. Jardim MC, Nogueira RL, Graeff FG, Nunes-de-Souza RL (1999). Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Res Bull 48:407-411.
22. Kralic JE, O'Buckley TK, Khisti RT, Hodge CW, Homanics GE, Morrow AL (2002). GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 43:685-694.
23. Maciejak P, Krzascik P, Czlonkowska AI, Szyndler J, Bidzinski A, Walkowiak J, et al. (2002). Antagonism of picrotoxin-induced changes in dopamine and serotonin metabolism by allopregnanolone and midazolam. Pharmacol Biochem Behav 72:987-991.
24. McGaugh JL, McIntyre CK, Power AE (2002). Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol Learn Mem 78:539-552.
25. Menard J, Treit D (1999). Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23:591-613.
26. Mi XJ, Chen SW, Wang WJ, Wang R, Zhang YJ, Li WJ, Li YL (2005). Anxiolytic-like effect of paeonol in mice. Pharmacol Biochem Behav 81:683-687.
27. Morrison AR, Sanford LD, Ross RJ (2000). The amygdala: a critical modulator of sensory influence on sleep. Biol Signals Recept 9:283-296.
28. Muller J, Corodimas KP, Fridel Z, LeDoux JE (1997). Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli. Behav Neurosci 111:683-691.
29. Nazar M, Siemiatkowski M, Czlonkowska A, Sienkiewicz-Jarosz H, Plaznik A (1999). The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. J Neural Transm 106:369-381.
30. National Research Council (1996). Guide for the care and use of laboratory animals. Washington DC. National Academy Press.
31. Nunes-de-Souza RL, Canto-de-Souza A, da-Costa M, Fornari RV, Graeff FG, Pela IR (2000). Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology (Berlin) 150:300-310.
32. Pandossio JE, Brandao ML (1999). Defensive reactions are counteracted by midazolam and muscimol and elicited by activation of glutamate receptors in the inferior colliculus of rats. Psychopharmacology 142:360-368.
33. Paxinos G, Franklin K (2001). The mouse brain in stereotaxic coordinates. New York Academic Press.
34. Pesold C, Treit D (1995). The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671:213-221.
35. Petersen EN, Braestrup C, Scheel-Kruger J (1985). Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors. Neurosci Lett 53:285-288.
36. Phillips TJ, Shen EH (1996). Neurochemical bases of locomotion and ethanol stimulant effects. Int Rev Neurobiol 39:243-282.
37. Plaznik A, Kostowski W, Stefanski R (1989). The influence of antidepressive treatment on GABA-related mechanisms in the rat hippocampus: behavioral studies. Pharmacol Biochem Behav 33:749-753.
38. Plaznik A, Jessa M, Bidzinski A, Nazar M (1994). The effect of serotonin depletion and intra-hippocampal midazolam on rat behavior in the Vogel conflict test. Eur J Pharmacol 257:293-296.
39. Prut L, Belzung C (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33.
40. Sanders SK, Shekhar A (1991). Blockade of GABAA receptors in the region of the anterior basolateral amygdala of rats elicits increases in heart rate and blood pressure. Brain Res 567:101-110.
41. Sanders SK, Shekhar A (1995). Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol Psychiatry 37:473-476.
42. Sanford LD, Parris B, Tang X (2002). GABAergic regulation of the central nucleus of the amygdala: implications for sleep control. Brain Res 956:276-284.
43. Schenberg LC, Bittencourt AS, Sudre ECM, Vargas LC (2001). Modeling panic attacks. Neurosci Biobehav Rev 25:647-659.
44. Shibata S, Yamashita K, Yamamoto E, Ozaki T, Ueki S (1989). Effects of benzodiazepine and GABA antagonists on anticonflict effects of anti-anxiety drugs injected into the rat amygdala in a water-lick suppression test. Psychopharmacology (Berlin) 98:38-44.
45. Silva MA, Tomaz C (1995). Amnesia after diazepam infusion into basolateral but not central amygdala of Rattus norvegicus. Neuropsychobiology 32: 31-36.
46. Smith TA (2001). Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br J Biomed Sci 58:111-121.
47. Soderpalm B, Svensson L, Hulthe P, Johannessen K, Engel JA (1991). Evidence for a role for dopamine in the diazepam locomotor stimulating effect. Psychopharmacology (Berlin) 104:97-102.
48. Stefanski R, Palejko W, Bidzinski A, KostowskiW, Plaznik A (1993). Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacology 32:977-985.
49. Teuber L, Watjens F, Jensen LH (1999). Ligands for the benzodiazepine binding site - a survey. Curr Pharm Des 5:317-343.
50. Turski WA, Cavalheiro EA, Calderazzo-Filho LS, Kleinrok Z, Czuczwar SJ, Turski L (1985). Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience 14:37-53.
51. Vogel HG, Vogel WH (2002.) Drug discovery and evaluation: pharmacological assays. New York: Springer.
52. Yasoshima Y, Yamamoto T (2005). Effects of midazolam on the expression of conditioned taste aversion in rats. Brain Res 1043:115-123.
53. Zangrossi H Jr, Viana MB, Graeff FG (1999). Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur J Pharmacol 369:267-270.
54. Zarrindast MR, Ahmadi S, Haeri-Rohani A, Rezayof A, Jafari MR, Jafari-Sabet M (2004). GABA(A) receptors in the basolateral amygdala are involved in mediating morphine reward. Brain Res 1006:49-58.
55. Zhang WN, Bast T, Feldon J (2000). Microinfusion of the non-competitive N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine) into the dorsal hippocampus of Wistar rats does not affect latent inhibition and prepulse inhibition, but increases startle reaction and locomotor activity. Neuroscience 101:589-599.